Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.
Method Article
Co-translational interactions play a crucial role in nascent-chain modifications, targeting, folding, and assembly pathways. Here, we describe Selective Ribosome Profiling, a method for in vivo, direct analysis of these interactions in the model eukaryote Saccharomyces cerevisiae.
In recent years, it has become evident that ribosomes not only decode our mRNA but also guide the emergence of the polypeptide chain into the crowded cellular environment. Ribosomes provide the platform for spatially and kinetically controlled binding of membrane-targeting factors, modifying enzymes, and folding chaperones. Even the assembly into high-order oligomeric complexes, as well as protein-protein network formation steps, were recently discovered to be coordinated with synthesis.
Here, we describe Selective Ribosome Profiling, a method developed to capture co-translational interactions in vivo. We will detail the various affinity purification steps required for capturing ribosome-nascent-chain complexes together with co-translational interactors, as well as the mRNA extraction, size exclusion, reverse transcription, deep-sequencing, and big-data analysis steps, required to decipher co-translational interactions in near-codon resolution.
Selective Ribosome Profiling (SeRP) is the only method, to date, that captures and characterizes co-translational interactions, in vivo, in a direct manner1,2,3,4,5,6. SeRP enables global profiling of interactions of any factor with translating ribosomes in near codon resolution2,7.
The method relies on flash freezing of growing cells and preserving active translation. Cell lysates are then treated with RNase I to digest all mRNA in the cell except ribosome-protected mRNA fragments termed "ribosome footprints". The sample is then split into two parts; one part is directly used for the isolation of all the cellular ribosomal footprints, representing all ongoing translation in the cell. The second part is used for the affinity-purification of the specific subset of ribosomes associated with a factor of interest, for example: modifying enzymes, translocation factors, folding chaperones, and complex-assembly interactions. The affinity-purified ribosomal footprints are collectively termed the interactome. Then, the ribosome-protected mRNAs are extracted and used for cDNA library generation, followed by deep sequencing.
Comparative analysis of the total translatome and interactome samples allows for the identification of all orfs which associate with the factor of interest, as well as characterization of each orf interaction profile. This profile reports the precise engagement onset and termination sequences from which one can infer the decoded codons and the respective residues of the emerging polypeptide chain, as well as on the ribosome speed variations during the interaction7,8. Figure 1 depicts the protocol as a schematic.
Figure 1: An overview of the SeRP protocol. This protocol can be performed in its entirety within 7-10 days. Please click here to view a larger version of this figure.
Access restricted. Please log in or start a trial to view this content.
1. Generating strains for Selective Ribosome Profiling
NOTE: Selective Ribosome Profiling (SeRP) is a method that relies on affinity purification of factors of interest, to assess their mode of interaction with ribosomes-nascent chain complexes. Homologous recombination9, as well as CRISPR/Cas910 based methods are utilized to fuse various factors of interest with tags for affinity purifications. Such tags are GFP, for GFP-trap affinity purifications, TAP-tag for IgG-Sepharose beads purifications as well as AVI-Tag purified by avidin or streptavidin, to list a few successful examples from recent years.
2. Culture growth
3. Cell collection and lysis
Reagent | Amount per sample (µL) | Final concentration |
10 mg/mL CHX (cycloheximide) | 220 | 0.5 mg/mL |
1M Tris-HCl pH 8.0 | 88 | 20 mM |
3M KCl | 205.7 | 140 mM |
1M MgCl2 | 26.4 | 6 mM |
1M PMSF | 4.4 | 1 mM |
NP-40 | 4.4 | 0.10% |
Protease inhibitor | 2 tablets | |
DNase I | 8.8 | 0.02 U/mL |
Final volume | 4,400 |
Table 1: Recipe for the lysis buffer master mix.
NOTE: Lysis buffer can be altered to contain more protease inhibitors (such as bestatin, leupeptin, aprotinin, etc.) in case the protein of interest is very unstable, but it is important to avoid EDTA in order to maintain the ribosome's small and large subunits assembled during the following steps. For similar reasons, always maintain at least 6 mM MgCl2 in the buffer solution.
CAUTION: HCl is highly corrosive and PMSF is toxic. Wear gloves and handle with care.
4. Purification of ribosome-nascent-chains complexes for SeRP
Reagent | Amount per sample (µL) | Final concentration |
50% Sucrose | 200 | 25% |
1M Tris-HCl pH 8.0 | 8 | 20 mM |
3M KCl | 18.7 | 140 mM |
1M MgCl2 | 4 | 10 mM |
100 mg/mL CHX | 0.4 | 0.1 mg/mL |
Protease inhibitor | 1 tablet | |
Final volume | 400 |
Table 2: Recipe for sucrose cushion master mix.
Reagent | Amount per sample (µL) | Final concentration |
10 mg/mL CHX | 50 | 0.1 mg/mL |
1M Tris-HCl pH 8.0 | 100 | 20 mM |
3M KCl | 233 | 140 mM |
1M MgCl2 | 50 | 10 mM |
1M PMSF | 5 | 1 mM |
NP-40 | 0.5 | 0.01% |
Protease inhibitor | 2 tablets | |
50% Glycerol | 1,000 | 10% |
Final volume | 5,000 |
Table 3: Recipe for the wash buffer master mix.
5. cDNA library preparation for deep sequencing
Reagent | Amount per sample (µL) | Final concentration |
50% sterile-filtered PEG 8000 | 16 | 20% |
DMSO | 4 | 10% |
10× T4 RNA ligase 2 buffer | 4 | 1x |
SUPERase-In RNase Inhibitor | 2 | 2 U |
10 mM adenylated linker 3-L1 | 0.1 | 25 µM |
DEPC-treated water | 2.9 | |
Final volume | 29 |
Table 4: Recipe for 3' end ligation master mix.
Reagent | Amount per sample (µL) | Final concentration |
10 mM dNTPs | 1 | 0.5 mM |
25 µM Linker L(rt) | 0.5 | 625 nM |
DEPC-treated water | 1.5 | |
Final volume | 3 |
Table 5: Recipe for the reverse transcription buffer master mix prior to nucleic acids' denaturation.
Reagent | Amount per sample (µL) | Final concentration |
5× FS buffer | 4 | 1x |
SUPERase-In RNase Inhibitor | 1 | 2 U |
DTT 0.1 M | 1 | 5 mM |
Final volume | 6 |
Table 6: Recipe for the reverse transcription buffer master mix after nucleic acids' denaturation.
Reagent | Amount per sample (µL) | Final concentration |
10× CircLigase II buffer | 2 | 1x |
5 M Betaine (optional) | 1 | 0.25 M |
50 mM MnCl2 | 1 | 2.5 mM |
Final volume | 4 |
Table 7: Recipe for ssDNA circularization master mix.
Reagent | Amount per sample (µL) | Final concentration |
DEPC-treated water | 61.6 | |
5× Phusion HF reaction buffer | 17.6 | 1x |
10 mM dNTPs | 1.8 | 200 µM |
100 µM PCR forward primer | 0.2 | 225 nM |
HF Phusion polymerase | 0.8 | 1.6 U |
Final volume | 82 |
Table 8: Recipe for PCR amplification master mix.
Cycle | Denature (98 °C) | Anneal (60 °C) | Extend (72 °C) |
1 | 30 s | ||
2-16 | 10 s | 10 s | 5 s |
Table 10: PCR program for PCR reaction.
6. Data analysis
Access restricted. Please log in or start a trial to view this content.
As illustrated in the flow chart of this protocol (Figure 1), cells were grown to log phase, and then collected swiftly by filtration and lysed by cryogenic grinding. The lysate was then divided into two: one for total ribosome-protected mRNA footprints and the other for selected ribosome-protected mRNA footprints, on which we performed affinity purification to pull-down the tagged protein-ribosome-nascent chains complexes. We ensured tagged protein expression and the success of the pull-dow...
Access restricted. Please log in or start a trial to view this content.
Here, the protocol details the Selective Ribosome Profiling approach for capturing co-translational interactions in near codon resolution. As the ribosome rises as a hub for coordinating the nascent-chain emergence into the crowded cytoplasm, this is a crucial method to identify and characterize the various co-translational interactions required to ensure a functional proteome, as well as for studying various diseases. To date, SeRP is the only method that can capture and characterize these interactions, in a direct...
Access restricted. Please log in or start a trial to view this content.
The authors declare no conflicts of interest.
We would like to thank all the lab members for fruitful discussions and Muhammad Makhzumy for the critical reading of the manuscript. This work was funded by ISF (Israeli Science Foundation) grant 2106/20.
Access restricted. Please log in or start a trial to view this content.
Name | Company | Catalog Number | Comments |
3'-Phosphorylated 28 nt RNA control oligonucleotide | IDT | custom order | RNase free HPLC purification; 5'-AUGUAGUCGGAGUCGAGGCGC GACGCGA/3Phos/-3' |
Absolute ethanol | VWR | 20821 | |
Acid phenol–chloroform | Ambion | AM9722 | |
Antibody: mouse monclonal anti-HA | Merck | 11583816001 | 12CA5 |
Aprotinin | Roth | A162.3 | |
ATP* | NEB | P0756S | 10 mM |
Bacto agar | BD | 214030 | |
Bacto peptone | BD | 211820 | |
Bacto tryptone | BD | 211699 | |
Bacto yeast extract | BD | 212720 | |
Bestatin hydrochloride | Roth | 2937.2 | |
Chloroform | Merck | 102445 | |
CircLigase II ssDNA Ligase* | Epicentre | CL9025K | 100 U/μL |
Colloidal Coomassie staining solution | Roth | 4829 | |
cOmplete, EDTA-free protease inhibitor cocktail tablets | Roche Diagnostics | 29384100 | |
Cycloheximide | Biological Industries | A0879 | |
DEPC treated and sterile filtered water* | Sigma | 95284 | |
D-Glucose anhydrous | Merck | G5767-500G | |
Diethylpyrocarbonate | Roth | K028 | |
Dimethylsulfoxide* | Sigma-Aldrich | 276855 | |
DNA ladder, 10 bp O'RangeRuler* | Thermo Fisher Scientific | SM1313 | |
DNA loading dye* | Thermo Fisher Scientific | R0631 | 6× |
DNase I, recombinant | Roche | 4716728001 | RNAse free |
dNTP solution set* | NEB | N0446S | |
EDTA* | Roth | 8043 | |
Glycerol | VWR | 24388.260. | |
Glycine solution | Sigma-Aldrich | 67419-1ML-F | 1 M |
GlycoBlue | Ambion | AM9516 | 15 mg/mL |
HEPES | Roth | HN78.3 | |
HF Phusion polymerase* | NEB | M0530L | |
HK from S. cerevisiae | Sigma-Aldrich | H6380-1.5KU | |
Hydrochloric acid | AppliChem | A1305 | |
Isopropanol | Sigma-Aldrich | 33539 | |
Isopropyl β-D-1-thiogalactopyranoside | Roth | CN08 | |
Kanamycin | Roth | T832.4 | |
KCl | Roth | 6781.1 | |
KH2PO4 | Roth | 3904.1 | |
Leupeptin | Roth | CN33.4 | |
Linker L(rt) | IDT | custom order | |
Liquid nitrogen | |||
MgCl2 | Roth | KK36.3 | |
Na2HPO4 | Roth | P030.2 | |
Na2HPO4·2H2O | Roth | T879.3 | |
NaCl* | Invitrogen | AM97606 | 5 M |
NaH2PO4·H2O | Roth | K300.2 | |
NHS-activated Sepharose 4 fast-flow beads | GE Life Sciences | 17090601 | |
Nonidet P 40 substitute | Sigma | 74385 | |
Pepstatin A | Roth | 2936.2 | |
Phenylmethyl sulfonyl fluoride | Roth | 6367 | |
Precast gels | Bio-Rad | 5671034 | 10% and 12% |
RNase I | Ambion | AM2294 | |
SDS, 20% | Ambion | AM9820 | RNase free |
Sodium acetate* | Ambion | AM9740 | 3 M, pH 5.5 |
Sodium azide | Merck | S8032-100G | |
Sodium chloride | Roth | 9265 | |
Sodium hydroxide* | Sigma | S2770 | 1 N |
Sucrose | Sigma-Aldrich | 16104 | |
SUPERase-In RNase Inhibitor | Ambion | AM2694 | |
Superscript III Reverse Transciptase* | Invitrogen | 18080-044 | |
SYBR Gold* | Invitrogen | S11494 | |
T4 polynucleotide kinase* | NEB | M0201L | |
T4 RNA ligase 2* | NEB | M0242L | |
TBE polyacrylamide gel* | Novex | EC6215BOX | 8% |
TBE–urea polyacrylamide gel* | Novex | EC68752BOX | 10% |
TBE–urea polyacrylamide gel* | Novex | EC6885BOX | 15% |
TBE–urea sample buffer* | Novex | LC6876 | 2× |
Tris | Roth | 4855 | |
Tris* | Ambion | AM9851 | 1 M, pH 7.0 |
Tris* | Ambion | AM9856 | 1 M, pH 8.0 |
UltraPure 10× TBE buffer* | Invitrogen | 15581-044 | |
* - for library preparation | |||
gasket and spring clamp , 90 mm, | Millipore | XX1009020 | |
ground joint flask 1 L , | Millipore | XX1504705 |
Access restricted. Please log in or start a trial to view this content.
Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE
Zapytaj o uprawnieniaThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone